Logo image of MOTS

MOTUS GI HOLDINGS INC (MOTS) Stock Fundamental Analysis

USA - NASDAQ:MOTS - US62014P5044 - Common Stock

0.1735 USD
-0.09 (-34.06%)
Last: 4/15/2024, 8:19:47 PM
0.1512 USD
-0.02 (-12.85%)
After Hours: 4/15/2024, 8:19:47 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MOTS. MOTS was compared to 191 industry peers in the Health Care Equipment & Supplies industry. MOTS may be in some trouble as it scores bad on both profitability and health. MOTS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MOTS had negative earnings in the past year.
MOTS had a negative operating cash flow in the past year.
In the past 5 years MOTS always reported negative net income.
MOTS had a negative operating cash flow in each of the past 5 years.
MOTS Yearly Net Income VS EBIT VS OCF VS FCFMOTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M -25M

1.2 Ratios

MOTS has a Return On Assets of -178.25%. This is amonst the worse of the industry: MOTS underperforms 92.31% of its industry peers.
MOTS has a Return On Equity of -479.16%. This is amonst the worse of the industry: MOTS underperforms 88.21% of its industry peers.
Industry RankSector Rank
ROA -178.25%
ROE -479.16%
ROIC N/A
ROA(3y)-126.68%
ROA(5y)-106.33%
ROE(3y)-454.56%
ROE(5y)-332.05%
ROIC(3y)N/A
ROIC(5y)N/A
MOTS Yearly ROA, ROE, ROICMOTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MOTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MOTS Yearly Profit, Operating, Gross MarginsMOTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K -40K -50K

More info and screens

2

2. Health

2.1 Basic Checks

MOTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MOTS has more shares outstanding
MOTS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MOTS has an improved debt to assets ratio.
MOTS Yearly Shares OutstandingMOTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
MOTS Yearly Total Debt VS Total AssetsMOTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

MOTS has an Altman-Z score of -34.76. This is a bad value and indicates that MOTS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -34.76, MOTS is doing worse than 91.79% of the companies in the same industry.
MOTS has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.46, MOTS is not doing good in the industry: 62.05% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -34.76
ROIC/WACCN/A
WACC10.68%
MOTS Yearly LT Debt VS Equity VS FCFMOTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 1.76 indicates that MOTS should not have too much problems paying its short term obligations.
MOTS has a Current ratio of 1.76. This is in the lower half of the industry: MOTS underperforms 77.44% of its industry peers.
A Quick Ratio of 1.61 indicates that MOTS should not have too much problems paying its short term obligations.
MOTS's Quick ratio of 1.61 is on the low side compared to the rest of the industry. MOTS is outperformed by 67.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.61
MOTS Yearly Current Assets VS Current LiabilitesMOTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.99% over the past year.
The Revenue for MOTS has decreased by -46.00% in the past year. This is quite bad
The Revenue has been growing by 51.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)68.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.19%
Revenue 1Y (TTM)-46%
Revenue growth 3Y47.21%
Revenue growth 5Y51.48%
Sales Q2Q%-41.82%

3.2 Future

Based on estimates for the next years, MOTS will show a very strong growth in Earnings Per Share. The EPS will grow by 25.56% on average per year.
Based on estimates for the next years, MOTS will show a very strong growth in Revenue. The Revenue will grow by 206.79% on average per year.
EPS Next Y58.34%
EPS Next 2Y40.28%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue Next Year337.5%
Revenue Next 2Y301.56%
Revenue Next 3Y206.79%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MOTS Yearly Revenue VS EstimatesMOTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
MOTS Yearly EPS VS EstimatesMOTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -50 -100 -150 -200 -250

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MOTS. In the last year negative earnings were reported.
Also next year MOTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MOTS Price Earnings VS Forward Price EarningsMOTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MOTS Per share dataMOTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

MOTS's earnings are expected to grow with 25.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.28%
EPS Next 3Y25.56%

More info and screens

0

5. Dividend

5.1 Amount

MOTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOTUS GI HOLDINGS INC

NASDAQ:MOTS (4/15/2024, 8:19:47 PM)

After market: 0.1512 -0.02 (-12.85%)

0.1735

-0.09 (-34.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-18 2024-03-18/amc
Earnings (Next)05-08 2024-05-08/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners134.91%
Ins Owner Change0%
Market Cap872.70K
Analysts82.86
Price Target8.47 (4781.84%)
Short Float %0.12%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.83%
Min EPS beat(2)-4.82%
Max EPS beat(2)50.49%
EPS beat(4)3
Avg EPS beat(4)21.64%
Min EPS beat(4)-4.82%
Max EPS beat(4)50.49%
EPS beat(8)7
Avg EPS beat(8)19.82%
EPS beat(12)10
Avg EPS beat(12)16.65%
EPS beat(16)12
Avg EPS beat(16)14.53%
Revenue beat(2)0
Avg Revenue beat(2)-45.1%
Min Revenue beat(2)-68.63%
Max Revenue beat(2)-21.57%
Revenue beat(4)0
Avg Revenue beat(4)-52.61%
Min Revenue beat(4)-90.59%
Max Revenue beat(4)-21.57%
Revenue beat(8)0
Avg Revenue beat(8)-47.11%
Revenue beat(12)3
Avg Revenue beat(12)-20.84%
Revenue beat(16)4
Avg Revenue beat(16)-26.2%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.61%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.69
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)-28.56
EYN/A
EPS(NY)-11.9
Fwd EYN/A
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS0.06
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -178.25%
ROE -479.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-126.68%
ROA(5y)-106.33%
ROE(3y)-454.56%
ROE(5y)-332.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 23.06%
Cap/Sales 32.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.61
Altman-Z -34.76
F-Score3
WACC10.68%
ROIC/WACCN/A
Cap/Depr(3y)57.67%
Cap/Depr(5y)82.07%
Cap/Sales(3y)63.47%
Cap/Sales(5y)141.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.19%
EPS Next Y58.34%
EPS Next 2Y40.28%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-46%
Revenue growth 3Y47.21%
Revenue growth 5Y51.48%
Sales Q2Q%-41.82%
Revenue Next Year337.5%
Revenue Next 2Y301.56%
Revenue Next 3Y206.79%
Revenue Next 5YN/A
EBIT growth 1Y33.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.92%
OCF growth 3YN/A
OCF growth 5YN/A